Aerie Pharmaceuticals, Inc

Aerie Pharmaceuticals

Employees:
100
Market Cap:
$1.73 billion
Net Income:
$-99.06 million
NASDAQ:
AERI

Aerie Pharmaceuticals (NASDAQ: AERI) is a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aeries two lead product candidates are once-daily IOP-lowering therapies with novel mechanisms of action to treat patients with glaucoma or ocular hypertension. Wikipedia

Aerie Pharmaceuticals
Employees:
100
Market Cap:
$1.73 billion
Net Income:
$-99.06 million
NASDAQ:
AERI

Aerie Pharmaceuticals (NASDAQ: AERI) is a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aeries two lead product candidates are once-daily IOP-lowering therapies with novel mechanisms of action to treat patients with glaucoma or ocular hypertension. Wikipedia